 |
Administrative/Clinical
Offices:
Hospital of the University of Pennsylvania
3400 Spruce Street
4 Silverstein Pavilion
Philadelphia, PA 19104
Executive Assistant: Anita Rodriguez
Lead Administrative Assistant: Denise Orr
Administrative Telephone: 215-662-2165
Administrative Fax: 215-614-0363
Patient Appointments: 215-662-2050
Contact
Information (internal use only)
jeffrey.drebin@uphs.upenn.edu  |
Jeffrey
A. Drebin, MD, PhD, FACS, has been appointed Chair of the
Department of Surgery at Penn Medicine, and has been appointed the
14th John Rhea Barton Professor of Surgery at the University of Pennsylvania
School of Medicine. A tradition established in 1878, the Barton Professorship
was the nation’s first endowed medical chair in any discipline.
In his new position, Dr. Drebin will oversee a diverse range of programs
and services spanning 10 divisions in the Department of Surgery, including
advanced patients care, basic and clinical research and the surgical
education program. He assumed his new role on February 1, 2009.
A graduate of Harvard Medical School, Dr. Drebin continued his surgical
training at the Johns Hopkins University School of Medicine before
joining the faculty at the Washington University School of Medicine
in St. Louis. In 2004 he was recruited to the University of Pennsylvania
School of Medicine as the Chief of the Division of Gastrointestinal
Surgery and vice-chairman for research for the Department of Surgery.
His many clinical interests include pancreatic cancer; acute and chronic
pancreatitis; the use of new technologies to manage liver tumors;
disorders of the bile ducts and management of gallbladder disease.
Dr. Drebin has published more than 70 peer-reviewed research papers
and numerous book chapters and reviews, many of which help increase
our understanding of the molecular biology of cancer, provide pre-clinical
support for the development of novel treatments or address advances
in clinical care of patients with gastrointestinal malignancies.
A Foundation in Research
Currently the William Maul Measey Professor in Surgical Research
at Penn, Dr. Drebin’s research has contributed significantly
to our understanding of the genetic origins of cancer. His classic
work with monoclonal antibodies directed against the human epidermal
growth factor receptor 2 (HER2/neu) protein provided the scientific
foundation for the evolution of targeted therapeutics for cancer
and the led to the development of the first generation of targeted
monoclonal antibody drugs for the treatment of breast cancer. Dr.
Drebin’s laboratory continues to explore new approaches to
understanding the molecular biology of colon, liver and pancreatic
cancers. Current research efforts are focused on novel approaches
to the targeted therapy of these gastrointestinal malignancies.
National Reputation
Dr. Drebin has been recognized by many professional and scientific
societies. At the national level, he has served in leadership roles
with a number of organizations, including the American College of
Surgeons and the Society of Surgical Oncology. He has also served
on study sections and scientific review groups for the National
Cancer Institute, the Department of Defense and other biomedical
research organizations. He was recently voted President-Elect of
the Society for Clinical Surgery, one of the oldest and most prestigious
surgical societies in the nation.
About the Department of Surgery at Penn Medicine
The Department of Surgery at Penn is among the top academic departments
of its kind in the nation. For 238 years, the Department has honored
its history by preserving the principles upon which it and the School
of Medicine were founded, while simultaneously setting the standards
for the future of medicine. Committed to supporting Penn Medicine
and its goals, the surgical faculty is devoted to providing the
best possible patient care and the generation of new knowledge,
a pursuit reflected in their strong commitment to student teaching
and housestaff training in the operating room, clinic, and research
laboratory, and by their contributions to national and international
scientific meetings and journals.
|